Digital medicine
A new Digital Measures Playbook was unveiled to help doctors and companies develop safe and effective clinical measures across patient care, research and public health. This is the latest multidisciplinary effort co-led by Elektra Labs and the Digital Medicine Society (DiME), a volunteer professional group created to drive scientific progress and broad acceptance of digital medicine to enhance public health in partnership with industry and academia.
The goal of The Playbook is to is provide an essential guide for successful remote monitoring across clinical research, clinical care, and public health. It is the result of collaborators from Genentech, a member of the Roche Group, Elektra Labs, Koneksa, Myokardia, Sage Bionetworks, Scripps Research as well as DiME. This first guide will be followed by an educational series, The PlaybookMasterclass, with interdisciplinary experts leading instructional sessions.
The value of remote patient monitoring dramatically increased with the COVID-19 pandemic as doctors need to closely track concerning symptoms such as worsening dyspnea from a distance. Physician scientists have called for digital systems that can provide vigilant evaluations of patients in the home for COVID-19 and also could be adapted to manage a variety of clinical conditions including hypertension, diabetes, or heart failure, where frequent human contact might be supplemented or partially replaced with digital automation and remote monitoring.
The current public health crises requires improvements in remotely monitoring and managing clinical research, routine care, and public health initiatives.The Playbookwill help address clinicians possible lack of experience implementing remote technologies by merging various frameworks for a 'how to' guide. Remote monitoring technologies are now advanced in their capabilities to detect symptoms of health and disease," said Jennifer Goldsack, executive director of DiME.
A critical benefit of remote monitoring using connected sensors is to offer a more holistic view of disease and lived experience by collecting important medical information continuously. The Playbookwill provide the foundational elements of developing and deploying high quality digital clinical measures that cut across use cases and positioning our field for a shared digital health data ecosystem, said Andy Coravos, CEO of Elektra Labs.
COVID-19 has been called an digital accelerant for remote monitoring while patients stay away from clinical settings. As research and care shift from hospital to home, there has been more adoption in the past few months in remote technologies. However, the need for sophisticated use of endpoints and digital data continues. For example, questions persist such as which digital clinical measures will best predict COVID-19 while patients are still pre-symptomatic.
Healthcare data
Efforts like the Playbook help address some concerning aspects of healthcare as costs continue to be unacceptably high coupled with with poor outcomes. Remote monitoring systems have the potential to shift this trend and be more patient-centered. Simultaneously, consumer technology giants such as Apple, Google Verily, Fitbit and Samsung have gotten clearances for personal monitoring devices, and are beginning to get broad adoption with the public, yet researchers and doctors need guidelines for how to use digital health data from remote devices.
Benchmarking digital clinical measures is an essential step in building confidence in how doctors interpret data from remote monitoring. The Playbook helps establish a roadmap for foundational processes in successful remote monitoring. Additionally different types of digital endpoints can be used in clinical trials, and to provide different levels of evidence about new medical product and interventions.
Go here to see the original:
Digital Medicine And Remote Monitoring Receives Boost From New Playbook - Forbes